Drew Ranieri

Stock Analyst at Morgan Stanley

(1.19)
# 3,714
Out of 5,044 analysts
167
Total ratings
44.44%
Success rate
-12.49%
Average return

Stocks Rated by Drew Ranieri

Globus Medical
Jul 15, 2025
Maintains: Overweight
Price Target: $75$68
Current: $62.75
Upside: +8.37%
Organogenesis Holdings
Mar 5, 2025
Maintains: Equal-Weight
Price Target: $4$6
Current: $4.19
Upside: +43.20%
Alphatec Holdings
Dec 2, 2024
Assumes: Equal-Weight
Price Target: $9.5$10
Current: $16.65
Upside: -39.94%
Stryker
Dec 2, 2024
Upgrades: Overweight
Price Target: $370$445
Current: $375.93
Upside: +18.37%
SI-BONE
Aug 6, 2024
Maintains: Overweight
Price Target: $21$19
Current: $15.79
Upside: +20.33%
Integra LifeSciences Holdings
Jul 15, 2024
Maintains: Underweight
Price Target: $24$27
Current: $15.56
Upside: +73.52%
Treace Medical Concepts
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $5.5$8
Current: $6.84
Upside: +16.96%
Stevanato Group
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $26$22
Current: $25.78
Upside: -14.66%
NeuroPace
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $9.5$8
Current: $10.62
Upside: -24.67%
Outset Medical
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $75$83
Current: $14.21
Upside: +480.58%
Maintains: Overweight
Price Target: $42$38
Current: $20.06
Upside: +89.43%
Maintains: Equal-Weight
Price Target: $88$96
Current: $50.36
Upside: +90.63%
Maintains: Underweight
Price Target: $28$26
Current: $11.58
Upside: +124.53%
Maintains: Overweight
Price Target: $290$295
Current: $184.21
Upside: +60.14%
Maintains: Equal-Weight
Price Target: $236$280
Current: $130.58
Upside: +114.43%
Maintains: Overweight
Price Target: $11$5
Current: $6.94
Upside: -27.95%
Maintains: Overweight
Price Target: $72$70
Current: $22.86
Upside: +206.21%
Maintains: Equal-Weight
Price Target: $325$300
Current: $545.39
Upside: -44.99%